Dechra Pharmaceuticals (LSE:DPH) Price-to-Tangible-Book : (As of May. 20, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-20), Dechra Pharmaceuticals's share price is £38.66. Dechra Pharmaceuticals's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was £-1.47. Hence, Dechra Pharmaceuticals's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Dechra Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Dechra Pharmaceuticals's highest Price to Tangible Book Ratio was 73.83. The lowest was 31.11. And the median was 52.47.

LSE:DPH's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.4
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Dechra Pharmaceuticals's share price is £38.66. Dechra Pharmaceuticals's Book Value per Sharefor the quarter that ended in Jun. 2023 was £6.63. Hence, Dechra Pharmaceuticals's P/B Ratio of today is 5.83.

Dechra Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Dechra Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dechra Pharmaceuticals Price-to-Tangible-Book Chart

Dechra Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

Dechra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Dechra Pharmaceuticals's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's Price-to-Tangible-Book falls into.

Dechra Pharmaceuticals Price-to-Tangible-Book Calculation

Dechra Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	38.66	/	-1.468
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Dechra Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

DPHAY:USA DPHl:UK 1PK:Germany

Address

24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA

Website

https://www.dechra.com

Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines